{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:23:55Z","timestamp":1770017035459,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s11910-003-0066-1","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T09:55:08Z","timestamp":1188467708000},"page":"143-148","source":"Crossref","is-referenced-by-count":13,"title":["Treatment approaches for children with Tourette\u2019s syndrome"],"prefix":"10.1007","volume":"3","author":[{"given":"Bennett L.","family":"Lavenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"66_CR1","first-page":"369","volume-title":"Advances in Neurology","author":"FJ Leckman","year":"2001","unstructured":"Leckman FJ, Cohen DJ, Goetz CG, Jankovic J: Tourette Syndrome. InAdvances in Neurology, Vol 85. Edited byCohenDJ, JankovicJ,GoetzCG. Philadelphia: Lippincott Williams & Wilkins; 2001:369\u2013390. A major review by experts in the field that serves as the basis for much work currently and previously."},{"key":"66_CR2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMra010032","volume":"16","author":"J Jankovic","year":"2001","unstructured":"JankovicJ: Tourette\u2019s syndrome. N Engl J Med 2001, 16:1184\u20131192. A recent review paper in the field not overly specific for children, but scholarly and concise. The bibliography is essentially complete although the text is brief.","journal-title":"N Engl J Med"},{"key":"66_CR3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-7258(99)00029-7","volume":"84","author":"G Emilien","year":"1999","unstructured":"Emilien G, Malaoteaux PM, Gevits M, Hoogenberg K: Dopamine receptors. Physiological understanding to therapeutic intervention potential. Pharmacol Ther 1999, 84:133\u201356.","journal-title":"Pharmacol Ther"},{"key":"66_CR4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004583-199901000-00024","volume":"38","author":"M Ernst","year":"1999","unstructured":"Ernst M, Zametkin AJ, Jons PH, Matochik P: High presynaptic dopaminergic activity in children with Tourette\u2019s disorder. J Am Acad Child Adolesc Psychiatry 1999, 38:86\u201394.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"66_CR5","first-page":"31","volume-title":"Advances in Neurology","author":"CG Goetz","year":"2001","unstructured":"Goetz CG, Kampoliti K: Tourette Syndrome. Rating scales and quantitative assessment in tics. InAdvances in Neurology, Vol 85. Edited byCohenCG, KampolitiK. Philadelphia: Lippincot Williams & Wilkins; 2001:31\u201342."},{"key":"66_CR6","first-page":"355","volume-title":"Advances in Neurology","author":"AE Lang","year":"2001","unstructured":"LangAE: Tourette Syndrome: update on treatment of tics. In Advances in Neurology, Vol. 85. Edited by CohenDJ, JankovicJ, GoetzCG. Philadelphia: Lippincott Williams & Wilkins; 2001:355\u2013362."},{"key":"66_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004583-199501000-00013","volume":"34","author":"RD Hunt","year":"1995","unstructured":"Hunt RD, Arnsten AF, Asbell MD: An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995, 34:50\u201354.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"66_CR8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","volume":"154","author":"FR Sallee","year":"1997","unstructured":"Sallee FR, Nesbitt L, Jackson LC, et al.: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette\u2019s disorder. Am J Psychiatry 1997, 154:1057\u20131062.","journal-title":"Am J Psychiatry"},{"key":"66_CR9","first-page":"915","volume":"51","author":"J Jankovic","year":"1999","unstructured":"JankovicJ: Gilles de la Tourette syndrome. Curr Ther 1999, 51:915\u2013919.","journal-title":"Curr Ther"},{"key":"66_CR10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.48.2.358","volume":"48","author":"J Jankovic","year":"1997","unstructured":"Jankovic J, Beach J: Long term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358\u2013362.","journal-title":"Neurology"},{"key":"66_CR11","first-page":"29","volume":"57","author":"RD Bruun","year":"1995","unstructured":"Bruun RD, Budman CL: Risperidone as a treatment for Tourette\u2019s syndrome. J Clin Psychiatry 1995, 57:29\u201331.","journal-title":"J Clin Psychiatry"},{"key":"66_CR12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","volume":"39","author":"FR Sallee","year":"2000","unstructured":"Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292\u2013299.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"66_CR13","first-page":"290","volume":"62","author":"C Budman","year":"2001","unstructured":"Budman C, Gayer A, Lesser M, et al.: An open-label study of the treatment efficacy of olanzapine for Tourette\u2019s disorder. J Clin Psychol 2001, 62:290\u2013294. An experience with a novel neuroepileptic in the growing field of agents used in treatment.","journal-title":"J Clin Psychol"},{"key":"66_CR14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/070674370104600220","volume":"46","author":"HC Parraga","year":"2001","unstructured":"Parraga HC, Parraga ML: Quetiapine treatment in patients with Tourette syndrome. Can J Psychiatry 2001, 46:184\u2013185.","journal-title":"Can J Psychiatry"},{"key":"66_CR15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00004714-199802000-00017","volume":"18","author":"J Schmider","year":"1998","unstructured":"Schmider J, Hoff P: Clozapine in Tourette\u2019s syndrome. J Clin Psychopharmacol 1998, 18:88\u201389.","journal-title":"J Clin Psychopharmacol"},{"key":"66_CR16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1212\/WNL.56.5.599","volume":"56","author":"HS Singer","year":"2001","unstructured":"Singer HS, Wendlandt J, Krieger M: Baclofen treatment in Tourette syndrome: a double blind placebo controlled, crossover trial. Neurology 2001, 56:599\u2013604.","journal-title":"Neurology"},{"key":"66_CR17","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneur.57.8.1190","volume":"57","author":"CH Kwak","year":"2000","unstructured":"Kwak CH, Hanna PA, Jankovic J: Botulinum treatment in the treatment of tics. Arch Neurol 2000, 57:1190\u20131193. A manuscript by some of the most experience neurologists in the area of botulinum toxin.","journal-title":"Arch Neurol"},{"key":"66_CR18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","volume":"56","author":"C Marras","year":"2001","unstructured":"Marras C, Andrews D, Sime E, et al.: Botulinum toxin for the treatment of simple motor tics. Neurology 2001, 56:605\u2013610.","journal-title":"Neurology"},{"key":"66_CR19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mds.870110413","volume":"11","author":"BL Scott","year":"1996","unstructured":"Scott BL, Jankovic J, Donovan DT: Botulinum injection into vocal cord in the treatment of malignant coproplalia associated with Tourettes syndrome. Mov Disorders 1996, 11:431\u2013433.","journal-title":"Mov Disorders"},{"key":"66_CR20","first-page":"125","volume":"2","author":"RD Buzan","year":"2000","unstructured":"Buzan RD, Sore J, O\u2019Brien C, et al.: Obsessive compulsive disorder: current treatment options. Neurology 2000, 2:125\u2013139.","journal-title":"Neurology"},{"key":"66_CR21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","volume":"62","author":"A Silver","year":"2001","unstructured":"Silver A, Shytle D, Phillip M, et al.: Transdermal nicotine and haloperidol in Tourette\u2019s Disorder: a double blind placebo controlled study. J Clin Psychiatry 2001, 62:707\u2013714.","journal-title":"J Clin Psychiatry"},{"key":"66_CR22","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","volume":"54","author":"D Gilbert","year":"2000","unstructured":"Gilbert D, Sethuram G, Sine L, et al.: Tourette\u2019s syndrome improvement with pergolide in a randomized double-blind, crossover trial. Neurology 2000, 54:1310\u20131315.","journal-title":"Neurology"},{"key":"66_CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.56.1.121","volume":"56","author":"M Anca","year":"2001","unstructured":"Anca M, Giladi N, Korczyn A: Ropinerole in Tourette\u2019s syndrome. Neurology 2001, 56:121.","journal-title":"Neurology"},{"key":"66_CR24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(98)05964-9","volume":"353","author":"V Vanderwalle","year":"1999","unstructured":"Vanderwalle V, van der Linden G, Groenewegen HG, et al.: Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of the thalamus. Lancet 1999, 353:724.","journal-title":"Lancet"},{"key":"66_CR25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo SE, Leonard HE, Garvey M, et al.: Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections. Clinical description of first 50 cases. Am J Psychiatry 1998, 155:264\u2013271.","journal-title":"Am J Psychiatry"},{"key":"66_CR26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","volume":"56","author":"KD Gadow","year":"1999","unstructured":"Gadow KD, Sverd J, Sprakin J, et al.: Long term methylphenidate therapy in children with comorbid attention deficit disorder and chronic multiple motor tics. Arch Gen Psychiatry 1999, 56:330\u2013336.","journal-title":"Arch Gen Psychiatry"},{"key":"66_CR27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004583-199501000-00013","volume":"34","author":"RD Hubt","year":"1995","unstructured":"Hubt RD, Arnsten AF, Asbell MD, et al.: An open trial of guanfacine in the treatment of attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1995, 34:50\u201354.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"66_CR28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1056-4993(18)30171-8","volume":"8","author":"MM Grados","year":"1999","unstructured":"Grados MM, Scahill L, Riddle MA: Pharmacotherapy in children and adolescents with obsessive compulsive disorder. Child Adolesc Psychiatry Clin North Am 1999, 8:617\u2013634.","journal-title":"Child Adolesc Psychiatry Clin North Am"},{"key":"66_CR29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4088\/JCP.v59n1109b","volume":"59","author":"BS Peterson","year":"1998","unstructured":"Peterson BS, Cohen DJ: The treatment of Tourette\u2019s syndrome, multimodal developmental intervention. J Clin Psychiatry 1998, 59:62\u201372.","journal-title":"J Clin Psychiatry"},{"key":"66_CR30","first-page":"343","volume-title":"Advances in Neurology","author":"MA Riddle","year":"2001","unstructured":"Riddle MA, Carlson J: Clinical psychopharmacology for Tourette syndrome and associated disorders. Tourette Syndrome. InAdvances in Neurology, vol. 85. Edited byCohen. Philadelphia: Lippincott, Williams & Wilkins; 2001:343\u2013354."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-003-0066-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-003-0066-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T17:33:17Z","timestamp":1708191197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-003-0066-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s11910-003-0066-1","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}